NCT07179562Not yet recruiting
Motivational Interviewing Program on the Self-Care in Idiopathic Pulmonary Fibrosis
Effectiveness of a Motivational Interviewing Program on the Self-Care Levels of Patients With Idiopathic Pulmonary Fibrosis
Source: ClinicalTrials.gov · Last updated 18 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
A specific tool developed to measure self-care in patients with Idiopathic Pulmonary Fibrosis (IPF) is the SC-IPFI, which is an adaptation of an already validated instrument for COPD. It is important to assess how motivational interviewing can influence the self-care behaviors of these patients, better evaluate their level of disease management, prevent the risk of exacerbations, and guide educational interventions. The primary objective of this study is to evaluate the effectiveness of a motivational interviewing program delivered remotely through video calls and digital platforms in improving the levels of self-care maintenance, self-care monitoring, and self-care management in patients with IPF. The study will also assess the effectiveness of the remotely delivered motivational interviewing program on self-efficacy, anxiety, disease-specific quality of life, therapy adherence, cough, dyspnea, exacerbations, and hospital admissions.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 124 (estimated)
- First submitted
- 16 Sept 2025
- Start date
- 1 Oct 2025
- Primary completion date
- 1 Oct 2027
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Diseases
- Idiopathic pulmonary fibrosis
- NCT number
- NCT07179562
What you commit to
- Study type: Interventional
- Planned participants: 124
- From 1 Oct 2025 to the primary completion date, 1 Oct 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- In advanced stage of disease (receiving oxygen therapy at 10 to 15 liters per minute).
Other illness
- Diagnosed with dementia,
Other
- Unable to speak, read, or write in Italian,
- Legally blind or deaf,
Who the study is looking for
- Diagnosed with idiopathic pulmonary fibrosis according to the 2018 guidelines of the American Thoracic Society/European Respiratory Society/Japanese Respiratory Society/Latin American Thoracic Association,
- Diagnosed with IPF for at least 1 year,
- Aged 18 years or older,
- Able to express willingness and provide consent to participate in the study,
- In possession of a tablet, smartphone, or computer and internet access via mobile or fixed network.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.